dr. rugo on pi3k and mtor inhibitors for the treatment of breast cancer
Published 11 years ago • 251 plays • Length 0:59Download video MP4
Download video MP3
Similar videos
-
6:21
pi3k inhibitors for hr breast cancer
-
6:13
clinical rationale for pi3k inhibitors in bc
-
2:15
management of mtor inhibitor side effects in breast cancer
-
1:15
dr. rugo discusses the future of angiogenesis in breast cancer
-
1:06
dr. rugo on guidelines for the treatment of metastatic breast cancer
-
3:39
role of pi3k inhibitors in hr metastatic breast cancer
-
0:55
dr. rugo on the future of extended adjuvant hormone therapy for breast cancer
-
0:52
dr. rugo discusses guidelines for metastatic breast cancer management
-
1:53
dr. hope rugo examines angiogenesis inhibition for advanced breast cancer
-
9:54
pi3k inhibition in breast cancer
-
1:42
dr. rugo on chemotherapy for metastatic breast cancer
-
1:20
dr. rugo on hormone therapy for patients with breast cancer
-
1:15
dr. rugo on unmet needs beyond second-line treatment in her2 breast cancer
-
1:55
dr. rugo on pathway blockade in breast cancer
-
2:35
dr. rugo on the phase iii sophia trial in her2 breast cancer
-
3:04
dr. rugo on 20-year span of breast cancer advancements
-
4:43
pi3k inhibitors in hr metastatic breast cancer
-
42:18
targeting the pi3k pathway in the therapy of breast cancer - by jose baselga, md, phd
-
1:24
dr. rugo on extended adjuvant hormone therapy for breast cancer